- Galera Therapeutics press release (NASDAQ:GRTX): Q4 GAAP EPS of -$0.10.
- As of December 31, 2023, Galera had cash and cash equivalents of $18.3 million.
Galera Therapeutics GAAP EPS of -$0.10
Recommended For You
More Trending News
About GRTX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| GRTX | - | - |
| Galera Therapeutics, Inc. | ||